Amneal Pharmaceuticals (AMRX) free cash flow

Free cash flow · fiscal 2025
$225.64M

Amneal Pharmaceuticals (AMRX) generated free cash flow of $225.64M in fiscal 2025 (the year ended December 31, 2025). That is 2.5% higher than the $220.11M of fiscal 2024. Figures as of 18 Nov 2026, 12:09 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$225.64M
Change on fiscal 2024
+2.5%
Growth, 5 years
−6.9% a year
Highest on record
$322.56Mfiscal 2020
Lowest on record
-$45.48Mfiscal 2019
Fiscal years on record
102016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Amneal Pharmaceuticals free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow shrank at a compound 6.9% a year. Across the 10 fiscal years on record (2016–2025), the highest was $322.56M in fiscal 2020 and the lowest -$45.48M in fiscal 2019.

History · 10 fiscal years

Free cash flow by fiscal year

Amneal Pharmaceuticals free cash flow, year by year

Amneal Pharmaceuticals (AMRX) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$225.64M 2.5% up
2024$220.11M 20.4% down
2023$276.39M—
2022-$25.50M 113.1% down
2021$194.09M 39.8% down
2020$322.56M—
2019-$45.48M 127.2% down
2018$167.14M 19.9% up
2017$139.42M—
2016-$7.70M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Amneal Pharmaceuticals and comparable companies
CompanyFree cash flowFiscal year
ABIVAX ABVX-€161.27M2025
Amneal Pharmaceuticals AMRX$225.64M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on AMRX

Amneal Pharmaceuticals, figure by figure

Amneal Pharmaceuticals (AMRX) overview: price, valuation and scorecardAll health care companies by market value

Amneal Pharmaceuticals free cash flow: questions and answers

What is Amneal Pharmaceuticals's free cash flow?

Amneal Pharmaceuticals (AMRX) generated free cash flow of $225.64M in fiscal 2025 (the year ended December 31, 2025). That is 2.5% higher than the $220.11M of fiscal 2024.

What is the growth rate of Amneal Pharmaceuticals's free cash flow?

Over the five fiscal years to 2025 free cash flow shrank at a compound 6.9% a year.

What are the highest and lowest free cash flow figures on record for Amneal Pharmaceuticals?

Across the 10 fiscal years on record (2016–2025), the highest was $322.56M in fiscal 2020 and the lowest -$45.48M in fiscal 2019.

How is Amneal Pharmaceuticals's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Amneal Pharmaceuticals it is on record here for 10 fiscal years, 2016 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Amneal Pharmaceuticals (AMRX) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/AMRX/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.